Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Debt to Assets Over TimeNormalizing
Percentile Rank43
3Y CAGR+36.0%
5Y CAGR-2.9%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+36.0%/yr
vs -30.9%/yr prior
5Y CAGR
-2.9%/yr
Recent acceleration
Acceleration
+66.9pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.29 | +3734.7% |
| 2024 | 0.01 | -3.7% |
| 2023 | 0.01 | -93.2% |
| 2022 | 0.12 | -54.0% |
| 2021 | 0.25 | -25.4% |
| 2020 | 0.34 | -23.0% |
| 2019 | 0.43 | -13.8% |
| 2018 | 0.50 | +50.8% |
| 2017 | 0.33 | -5.5% |
| 2016 | 0.35 | - |